Examkin

Soru

Zorluk: ZorEndocrinology and Metabolism

Review the following distinct laboratory profiles regarding calcium and phosphorus metabolism. Match each patient's serum and urine laboratory findings to the most accurate underlying pathophysiologic mechanism.

  • Serum calcium 11.811.8 mg/dL, phosphorus 2.22.2 mg/dL, intact PTH 99 pg/mL (low). Elevated PTH-related peptide.Ectopic production of a peptide mimicking parathyroid hormone action
  • Serum calcium 11.511.5 mg/dL, phosphorus 2.42.4 mg/dL, intact PTH 8585 pg/mL (high). Elevated 2424-hour urinary calcium excretion.Autonomous neoplastic proliferation of chief cells lacking feedback inhibition
  • Serum calcium 11.111.1 mg/dL, intact PTH 6565 pg/mL (high-normal). Urine calcium-to-creatinine clearance ratio is 0.0050.005.Inactivating mutation of the calcium-sensing receptor
  • Serum calcium 11.811.8 mg/dL, phosphorus 4.64.6 mg/dL, intact PTH 88 pg/mL (low). Elevated 1,251,25-dihydroxyvitamin D.Unregulated ectopic production of 11-alpha-hydroxylase by tissue macrophages
  • Serum calcium 7.97.9 mg/dL, phosphorus 6.26.2 mg/dL, intact PTH 410410 pg/mL (high). Decreased 1,251,25-dihydroxyvitamin D.Impaired renal phosphate excretion and decreased 11-alpha-hydroxylase activity

Cevap

Successfully matched all five clinical laboratory profiles to their defining pathophysiologic mechanisms based on calcium, phosphorus, PTH, and vitamin D axes.
Each laboratory pattern distinctively corresponds to a classic endocrine pathology. Ectopic PTHrP causes humoral hypercalcemia of malignancy (high Ca, low PTH). Autonomous parathyroid adenomas cause primary hyperparathyroidism (high Ca, high PTH, high urine Ca). Calcium-sensing receptor mutations cause FHH (high Ca, normal/high PTH, very low urine Ca clearance). Macrophage-driven 1-alpha-hydroxylase activity in granulomas causes vitamin D toxicity (high Ca, high phos, low PTH). Chronic kidney disease causes secondary hyperparathyroidism (low Ca, high phos, high PTH).

Adım Adım Çözüm

1
Analyze profile 1 (Hypercalcemia, low PTH, high PTHrP).
Matches ectopic production of a peptide mimicking parathyroid hormone action.
PTHrP acts on the PTH receptor to increase calcium and decrease phosphorus, but it does not cross-react in the intact PTH assay, leading to suppressed endogenous PTH.
2
Analyze profile 2 (Hypercalcemia, high PTH, high urine calcium).
Matches autonomous neoplastic proliferation of chief cells.
Elevated PTH despite hypercalcemia, coupled with hypercalciuria, indicates primary hyperparathyroidism without a calcium-sensing defect.
3
Analyze profile 3 (Hypercalcemia, normal/high PTH, low urine calcium clearance).
Matches inactivating mutation of the calcium-sensing receptor.
Familial hypocalciuric hypercalcemia alters the set-point for calcium sensing in the parathyroids and kidneys, causing hypercalcemia with relative hypocalciuria.
4
Analyze profile 4 (Hypercalcemia, high phosphorus, low PTH, high 1,25-OH Vit D).
Matches unregulated ectopic production of 1-alpha-hydroxylase by tissue macrophages.
Granulomatous diseases cause PTH-independent conversion of 25-OH to 1,25-OH vitamin D, causing high calcium and high phosphorus with appropriately suppressed PTH.
5
Analyze profile 5 (Hypocalcemia, high phosphorus, very high PTH).
Matches impaired renal phosphate excretion and decreased 1-alpha-hydroxylase activity.
Chronic kidney disease causes phosphate retention and decreased active vitamin D, leading to hypocalcemia and a robust secondary rise in PTH.

Anahtar Kavram

Differential diagnosis of calcium and phosphorus metabolic disorders based on parathyroid hormone and vitamin D dynamics.
Bu soruyu puanla

Konular

Endocrinology and Metabolism

Bu konudan daha fazla soru